Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

The known unknowns of HPV natural history
Patti E. Gravitt
Patti E. Gravitt
Published December 1, 2011
Citation Information: J Clin Invest. 2011;121(12):4593-4599. https://doi.org/10.1172/JCI57149.
View: Text | PDF
Review Series Article has an altmetric score of 49

The known unknowns of HPV natural history

  • Text
  • PDF
Abstract

The discovery that certain high-risk strains of human papillomavirus (HR-HPV) cause nearly 100% of invasive cervical cancer has spurred a revolution in cervical cancer prevention by promoting the development of viral vaccines. Although the efficacy of these vaccines has already been demonstrated, a complete understanding of viral latency and natural immunity is lacking, and solving these mysteries could help guide policies of cervical cancer screening and vaccine use. Here, we examine the epidemiological and biological understanding of the natural history of HPV infection, with an eye toward using these studies to guide the implementation of cervical cancer prevention strategies.

Authors

Patti E. Gravitt

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 Total
Citations: 8 11 13 7 7 3 16 3 9 9 16 10 25 11 1 149
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2016 (9)

Title and authors Publication Year
The CXCL12/CXCR4 Signaling Pathway: A New Susceptibility Factor in Human Papillomavirus Pathogenesis
F Meuris, L Carthagena, A Jaracz-Ros, F Gaudin, P Cutolo, C Deback, Y Xue, F Thierry, J Doorbar, F Bachelerie, C Meyers
PLoS pathogens 2016
Genetic variants within microRNA-binding site of RAD51B are associated with risk of cervical cancer in Chinese women
D Hang, W Zhou, M Jia, L Wang, J Zhou, Y Yin, H Ma, Z Hu, N Li, H Shen
Cancer Medicine 2016
High prevalence of human papillomaviruses in Ghanaian pregnant women
MH Schulze, FM Völker, R Lugert, P Cooper, K Hasenclever, U Groß, H Pfister, S Silling
Medical Microbiology and Immunology 2016
Re-detection vs . new acquisition of high-risk human papillomavirus in mid-adult women: HPV re-detection vs . new acquisition
TC Fu, JJ Carter, JP Hughes, Q Feng, SE Hawes, SM Schwartz, LF Xi, T Lasof, JE Stern, DA Galloway, LA Koutsky, RL Winer
International Journal of Cancer 2016
Human Papillomavirus DNA Detection in Older Women—Implications for Cancer Screening and Prevention
AC Ermel, KH Fife
The Journal of Infectious Diseases 2016
Pre-vaccine era cervical human papillomavirus infection among screening population of women in west Austria
W Borena, M Grünberger, A Widschwendter, KH Kraxner, E Marth, P Mayr, J Meier, N Ruth, AT Guerrero, C Marth, DH Laer
BMC Public Health 2016
Similar Risk Patterns After Cervical Screening in Two Large U.S. Populations: Implications for Clinical Guidelines
JC Gage, WC Hunt, M Schiffman, HA Katki, LA Cheung, O Myers, J Cuzick, N Wentzensen, W Kinney, PE Castle, CM Wheeler
Obstetrics & Gynecology 2016
Trends and determinants of human papillomavirus concordance among HIV-positive and HIV-negative heterosexual couples in Rakai, Uganda
MK Grabowski, PE Gravitt, RH Gray, D Serwadda, AD Redd, G Kigozi, X Kong, F Nalugoda, MJ Wawer, TC Quinn, AA Tobian
The Journal of Infectious Diseases 2016
O-linked N-acetylglucosamine transferase promotes cervical cancer tumorigenesis through human papillomaviruses E6 and E7 oncogenes
M Kim, YS Kim, H Kim, MY Kang, J Park, DH Lee, GS Roh, HJ Kim, SS Kang, GJ Cho, JK Park, JW Cho, JK Shin, WS Choi
Oncotarget 2016

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 5 news outlets
Referenced in 2 policy sources
Posted by 6 X users
436 readers on Mendeley
See more details